Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 February, 2018 14:16 IST
Glenmark Pharma secures USFDA nod for Clobetasol Propionate ointment
Source: IRIS | 21 Mar, 2017, 09.44AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Ointment USP, 0.05%, the generic version of Temovate Ointment, 0.05% of Fougera Pharmaceuticals Inc.

According to IMS Health sales data for the 12 month period ending January 2017, the Temovate Ointment, 0.05% market1 achieved annual sales of approximately USD 175.3 million.

Glenmark's current portfolio consists of 113 products authorized for distribution in the U.S. marketplace and approximately 64 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark (Q,N,C,F)* continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Shares of the company gained Rs 0.9, or 0.1%, to trade at Rs 881.25. The total volume of shares traded was 6,211 at the BSE (9.35 a.m., Tuesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
SSWL wins exports order from German OEM-BMW - 21-Feb-2018 12:15
BHEL bags Rs 10.34 bn captive power plant order - 21-Feb-2018 12:07
Reliance Ind to acquire 5% stake in Eros Int'l PLC - 21-Feb-2018 10:51
IRB Infra Developers receives appointed date for Kishangarh Gulabpura Tollway project - 21-Feb-2018 09:44
USFDA completes pre-approval inspection at Biocon Malyasia - 21-Feb-2018 09:31
CMI Energy bags order from Engineers India - 20-Feb-2018 14:27
Suven Life Sciences secures product patents in India and South Korea - 20-Feb-2018 10:47
IndusInd Bank intimates of no direct credit exposure to Nirav Modi - 20-Feb-2018 09:58
JSW Energy enters into MoU with Govt of Maharashtra - 20-Feb-2018 09:53
Subex partners with Pod Solution - 20-Feb-2018 09:49
Glenmark Pharma presents findings from Phase 2a study of GBR 830 - 19-Feb-2018 10:10
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer